FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3082993323> ?p ?o ?g. }

• W3082993323 endingPage "4539" @default.
• W3082993323 startingPage "4527" @default.
• W3082993323 abstract "Abstract Overexpression of IL2RA, which encodes the alpha chain of the IL2 receptor, is associated with chemotherapy resistance and poor outcome in acute myeloid leukemia (AML). The clinical potential of anti-IL2RA therapy is, therefore, being explored in early-stage clinical trials. Notwithstanding, only very limited information regarding the biological function of IL2RA in AML is available. Using genetic manipulation of IL2RA expression as well as antibody-mediated inhibition of IL2RA in human cell lines, mouse models, and primary patient samples, we investigated the effects of IL2RA on AML cell proliferation and apoptosis, and on pertinent signaling pathways. The impact of IL2RA on the properties of leukemic stem cells (LSC) and on leukemogenesis were queried. IL2RA promoted proliferation and cell-cycle activity and inhibited apoptosis in human AML cell lines and primary cells. These phenotypes were accompanied by corresponding alterations in cell-cycle machinery and in pathways associated with cell survival and apoptosis. The biological roles of IL2RA were confirmed in two genetically distinct AML mouse models, revealing that IL2RA inhibits differentiation, promotes stem cell–related properties, and is required for leukemogenesis. IL2RA antibodies inhibited leukemic, but not normal, hematopoietic cells and synergized with other antileukemic agents in this regard. Collectively, these data show for the first time that IL2RA plays key biological roles in AML and underscore its value as a potential therapeutic target in this disease. Significance: This study identifies IL2RA as a potential therapeutic target in AML, where it is shown to regulate proliferation, differentiation, apoptosis, stem cell–related properties, and leukemogenesis." @default.
• W3082993323 created "2020-09-08" @default.
• W3082993323 creator A5012403398 @default.
• W3082993323 creator A5024724352 @default.
• W3082993323 creator A5025156187 @default.
• W3082993323 creator A5025278295 @default.
• W3082993323 creator A5027978059 @default.
• W3082993323 creator A5038160508 @default.
• W3082993323 creator A5041101614 @default.
• W3082993323 creator A5055477573 @default.
• W3082993323 creator A5060467429 @default.
• W3082993323 date "2020-10-15" @default.
• W3082993323 modified "2023-10-18" @default.
• W3082993323 title "<i>IL2RA</i> Promotes Aggressiveness and Stem Cell–Related Properties of Acute Myeloid Leukemia" @default.
• W3082993323 cites W1185299649 @default.
• W3082993323 cites W1255676896 @default.
• W3082993323 cites W1840171540 @default.
• W3082993323 cites W1841276786 @default.
• W3082993323 cites W1841550020 @default.
• W3082993323 cites W1963933684 @default.
• W3082993323 cites W1974313653 @default.
• W3082993323 cites W1975627108 @default.
• W3082993323 cites W1982051091 @default.
• W3082993323 cites W1983949538 @default.
• W3082993323 cites W1985137297 @default.
• W3082993323 cites W1991286650 @default.
• W3082993323 cites W2022335352 @default.
• W3082993323 cites W2028896946 @default.
• W3082993323 cites W2032111684 @default.
• W3082993323 cites W2046569702 @default.
• W3082993323 cites W2052690356 @default.
• W3082993323 cites W205830912 @default.
• W3082993323 cites W2068796184 @default.
• W3082993323 cites W2084878791 @default.
• W3082993323 cites W2094155177 @default.
• W3082993323 cites W2109336877 @default.
• W3082993323 cites W2110502951 @default.
• W3082993323 cites W2113752195 @default.
• W3082993323 cites W2114144492 @default.
• W3082993323 cites W2122958542 @default.
• W3082993323 cites W2146506071 @default.
• W3082993323 cites W2151747638 @default.
• W3082993323 cites W2177783313 @default.
• W3082993323 cites W2199649107 @default.
• W3082993323 cites W2208333084 @default.
• W3082993323 cites W2343211206 @default.
• W3082993323 cites W2419140434 @default.
• W3082993323 cites W2560012305 @default.
• W3082993323 cites W2577524058 @default.
• W3082993323 cites W2589412374 @default.
• W3082993323 cites W2618202329 @default.
• W3082993323 cites W2738550771 @default.
• W3082993323 cites W2779715617 @default.
• W3082993323 cites W2792041720 @default.
• W3082993323 cites W2904928050 @default.
• W3082993323 cites W2942033591 @default.
• W3082993323 cites W2948398829 @default.
• W3082993323 cites W2953867576 @default.
• W3082993323 cites W2974308092 @default.
• W3082993323 cites W2980115897 @default.
• W3082993323 cites W2990611267 @default.
• W3082993323 cites W2994865712 @default.
• W3082993323 cites W4251857914 @default.
• W3082993323 doi "https://doi.org/10.1158/0008-5472.can-20-0531" @default.
• W3082993323 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32873636" @default.
• W3082993323 hasPublicationYear "2020" @default.
• W3082993323 type Work @default.
• W3082993323 sameAs 3082993323 @default.
• W3082993323 citedByCount "6" @default.
• W3082993323 countsByYear W30829933232022 @default.
• W3082993323 countsByYear W30829933232023 @default.
• W3082993323 crossrefType "journal-article" @default.
• W3082993323 hasAuthorship W3082993323A5012403398 @default.
• W3082993323 hasAuthorship W3082993323A5024724352 @default.
• W3082993323 hasAuthorship W3082993323A5025156187 @default.
• W3082993323 hasAuthorship W3082993323A5025278295 @default.
• W3082993323 hasAuthorship W3082993323A5027978059 @default.
• W3082993323 hasAuthorship W3082993323A5038160508 @default.
• W3082993323 hasAuthorship W3082993323A5041101614 @default.
• W3082993323 hasAuthorship W3082993323A5055477573 @default.
• W3082993323 hasAuthorship W3082993323A5060467429 @default.
• W3082993323 hasBestOaLocation W30829933232 @default.
• W3082993323 hasConcept C105696609 @default.
• W3082993323 hasConcept C109159458 @default.
• W3082993323 hasConcept C190283241 @default.
• W3082993323 hasConcept C203014093 @default.
• W3082993323 hasConcept C2778729363 @default.
• W3082993323 hasConcept C28328180 @default.
• W3082993323 hasConcept C29537977 @default.
• W3082993323 hasConcept C502942594 @default.
• W3082993323 hasConcept C54355233 @default.
• W3082993323 hasConcept C62112901 @default.
• W3082993323 hasConcept C86803240 @default.
• W3082993323 hasConcept C95444343 @default.
• W3082993323 hasConceptScore W3082993323C105696609 @default.
• W3082993323 hasConceptScore W3082993323C109159458 @default.
• W3082993323 hasConceptScore W3082993323C190283241 @default.
• W3082993323 hasConceptScore W3082993323C203014093 @default.

• next